Is Guardian Pharmacy Services, Inc. (GRDN) overvalued? · rev $377.4M
Guardian Pharmacy Services, Inc. (GRDN) is a medical care facilities company listed on US.
This page asks whether Guardian Pharmacy Services, Inc. (GRDN) looks expensive on cached numbers — not a short thesis.
Latest reported GRDN revenue for 2025-09-30 was $377.4M. Net income was $9.6M. Revenue was up 9.6% from 2025-06-30 to 2025-09-30. GRDN currently screens at market cap $1.25B.
GRDN currently screens at market cap $1.25B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GRDN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GRDN stock page for the full model, not this heading.
Not investment advice.